At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 19 enrolled
Drug / intervention
Endobarrier Linerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Trial of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner
In Brief
A Phase 2 clinical trial evaluating Endobarrier Liner for Obesity. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether the GI Endobarrier Liner can be reimplanted.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesChile
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedJun 2011
Primary CompletionNov 2011
Study CompletionSep 2012
TodayJul 2026
First PostedJun 14, 2011
Enrollment StartSep 1, 2010
Primary CompletionNov 1, 2011
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.0 years ago
Interventions
Endobarrier Linerdevice
Medical device placed endoscopically in the duodenum